AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Feb 11, 2025
30870_dirs_2025-02-11_e0037395-57b2-40ce-9998-f71e3bd86d07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-02-10
Reporting Person: Landry Robert E (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-10 | Non-Qualified Stock Option (Right to Buy) | $42.21 | A | 25538 | Acquired | 2035-02-12 | Common Stock (25538) | Direct |
Footnotes
F1: Initial grant to new director. Stock Options vest monthly over 3-years from the date of grant.
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18